Page last updated: 2024-10-23

atenolol and Craniocerebral Trauma

atenolol has been researched along with Craniocerebral Trauma in 2 studies

Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.

Craniocerebral Trauma: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cruickshank, JM2
Neil-Dwyer, G2
Hayes, Y2
Degaute, JP2
Kuurne, T2
Kytta, J2
Carruthers, ME2
Patel, S2
Vincent, JL1

Trials

2 trials available for atenolol and Craniocerebral Trauma

ArticleYear
Stress/catecholamine-induced cardiac necrosis. Reduction by beta 1-selective blockade.
    Postgraduate medicine, 1988, Feb-29, Volume: Spec No

    Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atenolol; Child; Clinical Trials as Topic; Craniocere

1988
Reduction of stress/catecholamine-induced cardiac necrosis by beta 1-selective blockade.
    Lancet (London, England), 1987, Sep-12, Volume: 2, Issue:8559

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Child; Clinical Trials as Topic; Cra

1987